| pubmed-article:16490581 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0004096 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0073992 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0117996 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0205322 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0585361 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C0021461 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
| pubmed-article:16490581 | lifeskim:mentions | umls-concept:C1721232 | lld:lifeskim |
| pubmed-article:16490581 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16490581 | pubmed:dateCreated | 2006-2-21 | lld:pubmed |
| pubmed-article:16490581 | pubmed:abstractText | This study compared the efficacy and tolerability of the combination of fluticasone propionate (FP) and salmeterol (SAL) delivered via a single hydrofluoroalkane (HFA) 134a metered-dose inhaler (MDI) with those of its 2 components alone delivered via a chlorofluorocarbon (CFC) MDI and placebo (PLA) delivered via HFA MDI in adolescent and adult patients with persistent asthma that was not controlled by medium doses (equivalent to FP 440-660 microg/d) of inhaled corticosteroids (ICSs). | lld:pubmed |
| pubmed-article:16490581 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16490581 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490581 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16490581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490581 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16490581 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:16490581 | pubmed:issn | 0149-2918 | lld:pubmed |
| pubmed-article:16490581 | pubmed:author | pubmed-author:DorinskyPaulP | lld:pubmed |
| pubmed-article:16490581 | pubmed:author | pubmed-author:NathanRobert... | lld:pubmed |
| pubmed-article:16490581 | pubmed:author | pubmed-author:ScottCatherin... | lld:pubmed |
| pubmed-article:16490581 | pubmed:author | pubmed-author:HouseKarenK | lld:pubmed |
| pubmed-article:16490581 | pubmed:author | pubmed-author:SchoafLynneL | lld:pubmed |
| pubmed-article:16490581 | pubmed:author | pubmed-author:EllsworthAnna... | lld:pubmed |
| pubmed-article:16490581 | pubmed:author | pubmed-author:RooklinAnthon... | lld:pubmed |
| pubmed-article:16490581 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16490581 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:16490581 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16490581 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16490581 | pubmed:pagination | 73-85 | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:meshHeading | pubmed-meshheading:16490581... | lld:pubmed |
| pubmed-article:16490581 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16490581 | pubmed:articleTitle | Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. | lld:pubmed |
| pubmed-article:16490581 | pubmed:affiliation | Asthma and Allergy Associates, Colorado Springs, Colorado 80907, USA. drrnathan@aol.com | lld:pubmed |
| pubmed-article:16490581 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16490581 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16490581 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16490581 | lld:pubmed |
